Publication | Open Access
Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis
90
Citations
32
References
2016
Year
InflammationNpc1l1 InhibitorAnti-inflammatoryDiet-induced Nonalcoholic SteatohepatitisMedicineLiver PhysiologyPathologyPotent Nrf2 ActivatorHepatotoxicityPharmacotherapyFatty Liver DiseasePharmacologyOxidative Stress
| Year | Citations | |
|---|---|---|
Page 1
Page 1